In Vitro-In Silico Tools for Streamlined Development of Acalabrutinib Amorphous Solid Dispersion Tablets
Open Access
- 13 August 2021
- journal article
- research article
- Published by MDPI AG in Pharmaceutics
- Vol. 13 (8) , 1257
Abstract
Amorphous solid dispersion (ASD) dosage forms can improve the oral bioavailability of poorly water-soluble drugs, enabling the commercialization of new chemical entities and improving the efficacy and patient compliance of existing drugs. However, the development of robust, high-performing ASD dosage forms can be challenging, often requiring multiple formulation iterations, long timelines, and high cost. In a previous study, acalabrutinib/hydroxypropyl methylcellulose acetate succinate (HPMCAS)-H grade ASD tablets were shown to overcome the pH effect of commercially marketed Calquence in beagle dogs. This study describes the streamlined in vitro and in silico approach used to develop those ASD tablets. HPMCAS-H and -M grade polymers provided the longest acalabrutinib supersaturation sustainment in an initial screening study, and HPMCAS-H grade ASDs provided the highest in vitro area under the curve (AUC) in gastric to intestinal transfer dissolution tests at elevated gastric pH. In silico simulations of the HPMCAS-H ASD tablet and Calquence capsule provided good in vivo study prediction accuracy using a bottom–up approach (absolute average fold error of AUC0-inf < 2). This streamlined approach combined an understanding of key drug, polymer, and gastrointestinal properties with in vitro and in silico tools to overcome the acalabrutinib pH effect without the need for reformulation or multiple studies, showing promise for reducing time and costs to develop ASD drug products.Keywords
This publication has 38 references indexed in Scilit:
- Drug–drug interactions with tyrosine-kinase inhibitors: a clinical perspectiveThe Lancet Oncology, 2014
- pH-Dependent Drug–Drug Interactions for Weak Base Drugs: Potential Implications for New Drug DevelopmentClinical Pharmacology & Therapeutics, 2014
- The effect of HPMCAS functional groups on drug crystallization from the supersaturated state and dissolution improvementInternational Journal of Pharmaceutics, 2014
- Prevalence of Acid-Reducing Agents (ARA) in Cancer Populations and ARA Drug–Drug Interaction Potential for Molecular Targeted Agents in Clinical DevelopmentMolecular Pharmaceutics, 2013
- Development of a Canine Model to Enable the Preclinical Assessment of Ph-dependent Absorption of Test CompoundsJournal of Pharmaceutical Sciences, 2011
- Hydroxypropyl Methylcellulose Acetate Succinate-Based Spray-Dried Dispersions: An OverviewMolecular Pharmaceutics, 2008
- Oral Absorption of Poorly Water-Soluble Drugs: Computer Simulation of Fraction Absorbed in Humans from a Miniscale Dissolution TestPharmaceutical Research, 2006
- A review of the physiology of the canine digestive tract related to the development ofin vitrosystemsNutrition Research Reviews, 1998
- Effect of Diffusion Layer pH and Solubility on the Dissolution Rate of Pharmaceutical Bases and their Hydrochloride Salts I: PhenazopyridineJournal of Pharmaceutical Sciences, 1985
- Omeprazole: A Study of Its Inhibition of Gastric pH and Oral Pharmacokinetics After Morning or Evening DosageGastroenterology, 1985